Announcements
Expression of concern regarding paper by Park et al, published on 25 June 2015: “Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015”, Euro Surveill. 2015;20(25):pii=21169. It has been brought to our attention that some of the authors may not have been informed about the content of the above paper. There is a lack of clarity regarding rights to use the data. The editorial team are investigating what action needs to be taken.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance


In this issue


Home Eurosurveillance Edition  2016: Volume 21/ Issue 9 Article 5
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 21, Issue 9, 03 March 2016
News
Eurosurveillance editorial team: WHO publishes viral hepatitis surveillance guide

+ Author affiliations


Citation style for this article: Eurosurveillance editorial team. WHO publishes viral hepatitis surveillance guide. Euro Surveill. 2016;21(9):pii=30151. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.9.30151


On 29 February 2016, the World Health Organization (WHO) released its first surveillance guide for hepatitis, ‘Technical considerations and case definitions to improve surveillance for viral hepatitis’ [1]. The document outlines key actions for improving hepatitis surveillance systems, and provides case definitions for viral hepatitis surveillance.

Viral hepatitis is a global public health problem of epidemic proportions and according to the Global Burden of Disease study [2], it causes approximately 1.46 million deaths each year. New infections caused by the five known hepatitis viruses – A, B, C, D and E (HAV, HBV, HCV, HDV and HEV) can be prevented; however, this relies on surveillance systems generating epidemiological information which is key in preventing and controlling hepatitis epidemics.

In recognition of the burden of viral hepatitis on global health, the World Health Assembly adopted resolutions in 2010 and 2014 [3,4] that called for a comprehensive approach to the prevention and control of viral hepatitis and mandated WHO to work closely with its Member States to develop the necessary guidelines for the surveillance, prevention and control of viral hepatitis.

In response, WHO developed these technical considerations that aim to help develop or strengthen the collection, analysis and reporting of data related to viral hepatitis.



References

  1. World Health Organization (WHO). Technical considerations and case definitions to improve surveillance for viral hepatitis. Technical report. Geneva: WHO. 29 Feb 2016. Available from: http://apps.who.int/iris/bitstream/10665/204501/1/9789241549547_eng.pdf?ua=1

  2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015;385(9963):117-71. DOI: 10.1016/S0140-6736(14)61682-2 PMID: 25530442

  3. World Health Organization (WHO). Resolution WHA63.18. Viral Hepatitis. In: Sixty-third World Health Assembly, Agenda item 11.12, 21 May 2010. Geneva: WHO. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_J3-en.pdf

  4. World Health Organization (WHO). Resolution WHA67.6. Hepatitis. In: Sixty-seventh World Health Assembly. Agenda item 12.3, Geneva, 19–24 May 2014. Geneva: WHO. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf



Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.